Ezra Holdings Limited (NASDAQ:EZRA) Shares Shorted: Short Interest Up 405.0% in October

Posted by Brian Himes on Oct 27th, 2026

Ezra Holdings Limited (NASDAQ:EZRA – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 43,558 shares, a growth of 405.0% from the September 30th total of 8,626 shares. Based on an average daily trading volume, of 711,287 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Several analysts recently issued reports on EZRA shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Ezra in a research note on Friday, October 2nd. Wall Street Zen downgraded Ezra from a “hold” rating to a “sell” rating in a report on Saturday, September 5th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Research Report on EZRA

Ezra Price Performance

Shares of Ezra stock traded down $0.01 during midday trading on Tuesday, reaching $2.22. 4,870 shares of the company’s stock traded hands, compared to its average volume of 765,104. The stock has a 50 day moving average of $2.54 and a 200-day moving average of $4.03. Ezra has a 12 month low of $1.75 and a 12 month high of $53.20.

Ezra (NASDAQ:EZRA – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($3.26) EPS for the quarter. The company had revenue of $2.11 million during the quarter.

Insider Buying and Selling at Ezra

In other Ezra news, VP Yaakov Beyman sold 9,120 shares of the firm’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $3.83, for a total value of $34,929.60. Following the sale, the vice president owned 2,967 shares of the company’s stock, valued at $11,363.61. This trade represents a 75.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alex Blumenfrucht sold 8,830 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $3.97, for a total transaction of $35,055.10. Following the completion of the transaction, the director owned 13 shares in the company, valued at $51.61. The trade was a 99.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 34,727 shares of company stock valued at $124,161 in the last quarter.

About Ezra

(Get Free Report)

Ezra Ltd. is a medical technology company focused on improving cancer screening through magnetic resonance imaging (MRI) and artificial intelligence. Its platform is designed to help clinicians identify potential cancers earlier by analyzing MRI scans of the body and highlighting areas that may require further evaluation.

The company offers full-body and organ-specific MRI screening services through its technology platform, with the goal of making preventive cancer screening more accessible and efficient.